243 related articles for article (PubMed ID: 7495736)
1. The two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genes.
Kern I; Steimle V; Siegrist CA; Mach B
Int Immunol; 1995 Aug; 7(8):1295-9. PubMed ID: 7495736
[TBL] [Abstract][Full Text] [Related]
2. The DMB promoter: delineation, in vivo footprint, trans-activation, and trans-dominant suppression.
Ting JP; Wright KL; Chin KC; Brickey WJ; Li G
J Immunol; 1997 Dec; 159(11):5457-62. PubMed ID: 9548486
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the expression of MHC class I and II by class II transactivator (CIITA) in hematopoietic cells.
Liu A; Takahashi M; Toba K; Zheng Z; Hashimoto S; Nikkuni K; Furukawa T; Koike T; Aizawa Y
Hematol Oncol; 1999 Dec; 17(4):149-60. PubMed ID: 10725870
[TBL] [Abstract][Full Text] [Related]
4. Identification of class II transcriptional activator-induced genes by representational difference analysis: discoordinate regulation of the DN alpha/DO beta heterodimer.
Taxman DJ; Cressman DE; Ting JP
J Immunol; 2000 Aug; 165(3):1410-6. PubMed ID: 10903745
[TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma induces major histocompatibility class II transactivator (CIITA), which mediates collagen repression and major histocompatibility class II activation by human aortic smooth muscle cells.
Butticè G; Miller J; Wang L; Smith BD
Circ Res; 2006 Mar; 98(4):472-9. PubMed ID: 16439692
[TBL] [Abstract][Full Text] [Related]
6. X box-like sequences in the MHC class II region maintain regulatory function.
Gomez JA; Majumder P; Nagarajan UM; Boss JM
J Immunol; 2005 Jul; 175(2):1030-40. PubMed ID: 16002703
[TBL] [Abstract][Full Text] [Related]
7. HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA: acquisition of antigen processing and presentation capacity.
Sartoris S; Valle MT; Barbaro AL; Tosi G; Cestari T; D'Agostino A; Megiovanni AM; Manca F; Accolla RS
J Immunol; 1998 Jul; 161(2):814-20. PubMed ID: 9670958
[TBL] [Abstract][Full Text] [Related]
8. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex.
Masternak K; Muhlethaler-Mottet A; Villard J; Zufferey M; Steimle V; Reith W
Genes Dev; 2000 May; 14(9):1156-66. PubMed ID: 10809673
[TBL] [Abstract][Full Text] [Related]
9. HLA-DMA and HLA-DMB gene expression functions through the conserved S-X-Y region.
Westerheide SD; Louis-Plence P; Ping D; He XF; Boss JM
J Immunol; 1997 May; 158(10):4812-21. PubMed ID: 9144496
[TBL] [Abstract][Full Text] [Related]
10. Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma.
Lu HT; Riley JL; Babcock GT; Huston M; Stark GR; Boss JM; Ransohoff RM
J Exp Med; 1995 Nov; 182(5):1517-25. PubMed ID: 7595221
[TBL] [Abstract][Full Text] [Related]
11. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
[TBL] [Abstract][Full Text] [Related]
12. Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation.
Masternak K; Reith W
EMBO J; 2002 Mar; 21(6):1379-88. PubMed ID: 11889043
[TBL] [Abstract][Full Text] [Related]
13. Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5.
Scholl T; Mahanta SK; Strominger JL
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6330-4. PubMed ID: 9177217
[TBL] [Abstract][Full Text] [Related]
14. Discoordinate expression of invariant chain and MHC class II genes in class II transactivator-transfected fibroblasts defective for RFX5.
Peijnenburg A; Van Eggermond MJ; Gobin SJ; Van den Berg R; Godthelp BC; Vossen JM; Van den Elsen PJ
J Immunol; 1999 Jul; 163(2):794-801. PubMed ID: 10395672
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional control of MHC genes in fetal trophoblast cells.
van den Elsen PJ; Gobin SJ; van der Stoep N; Datema G; Viëtor HE
J Reprod Immunol; 2001; 52(1-2):129-45. PubMed ID: 11600183
[TBL] [Abstract][Full Text] [Related]
16. CIITA-dependent and -independent class II MHC expression revealed by a dominant negative mutant.
Zhou H; Su HS; Zhang X; Douhan J; Glimcher LH
J Immunol; 1997 May; 158(10):4741-9. PubMed ID: 9144488
[TBL] [Abstract][Full Text] [Related]
17. Different levels of control prevent interferon-gamma-inducible HLA-class II expression in human neuroblastoma cells.
Croce M; De Ambrosis A; Corrias MV; Pistoia V; Occhino M; Meazza R; Giron-Michel J; Azzarone B; Accolla RS; Ferrini S
Oncogene; 2003 Oct; 22(49):7848-57. PubMed ID: 14586411
[TBL] [Abstract][Full Text] [Related]
18. Major histocompatibility class II HLA-DR alpha gene expression in thyrocytes: counter regulation by the class II transactivator and the thyroid Y box protein.
Montani V; Taniguchi SI; Shong M; Suzuki K; Ohmori M; Giuliani C; Napolitano G; Saji M; Fiorentino B; Reimold AM; Ting JP; Kohn LD; Singer DS
Endocrinology; 1998 Jan; 139(1):280-9. PubMed ID: 9421426
[TBL] [Abstract][Full Text] [Related]
19. Regulation of MHC class II genes: lessons from a disease.
Mach B; Steimle V; Martinez-Soria E; Reith W
Annu Rev Immunol; 1996; 14():301-31. PubMed ID: 8717517
[TBL] [Abstract][Full Text] [Related]
20. Quantitative control of MHC class II expression by the transactivator CIITA.
Otten LA; Steimle V; Bontron S; Mach B
Eur J Immunol; 1998 Feb; 28(2):473-8. PubMed ID: 9521055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]